Bridge Regulatory Affairs, LLC

← The SEC Ephemeris: the whole map

Bridge Regulatory Affairs, LLC octreotide hydrochloride extended- release

In the graph: all 2 documents (5 pages).

Application: NDA 218600
Ticker: Bridge Regulatory Affairs, LLC
Product: octreotide hydrochloride extended- release
Disease area: Not yet classified
Response path: Not yet classified
Complete Response Letters: June 10, 2026 · October 21, 2024

From FDA letters and SEC filings. Not investment or medical advice.

Group by

Build queue · replay at pipeline speed